Dr. Chaganti, founder of Cancer Genetics, Inc., was formerly the chief of Memorial Sloan-Kettering Cancer Center’s cytogenetics service, which was established
Noblewell is a contract research organization (CRO) that provides expertise in clinical trial development, management, and post approval services. Our responsiveness to client...